Convenio Medicamentos Secc. 216 y 262 Inyectables
Se requiere suscribir CONVENIO MEDICAMENTOS SECC. 216 Y 262 INYECTABLES para Farmcia del HTC.
24 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 2157-738-SE13 | 29-05-2013 | Laboratorio Sanderson S.A. | $434.112 |
| 2157-604-SE13 | 30-04-2013 | Productos Farmoquimicos Roche Limitada | $434.945 |
| 2157-608-SE13 | 30-04-2013 | Laboratorio Sanderson S.A. | $145.180 |
| 2157-607-SE13 | 30-04-2013 | Laboratorio Sanderson S.A. | $33.320 |
| 2157-606-SE13 | 30-04-2013 | Pfizer Chile S.A. | $2.760.800 |
| 2157-605-SE13 | 30-04-2013 | Farmaceutica Insuval S.A. | $226.100 |
| 2157-565-SE13 | 19-04-2013 | Aventis Pharma Holding Gmbh | $2.332.400 |
| 2157-564-SE13 | 19-04-2013 | Tecnofarma S.A. | $297.500 |
| 2157-552-SE13 | 18-04-2013 | Pfizer Chile S.A. | $5.521.600 |
| 2157-550-SE13 | 18-04-2013 | Novofarma Service S.A. | $1.061.789 |
| 2157-548-SE13 | 18-04-2013 | Productos Farmoquimicos Roche Limitada | $869.890 |
| 2157-549-SE13 | 18-04-2013 | Farmaceutica Insuval S.A. | $378.539 |
| 2157-551-SE13 | 18-04-2013 | Astrazeneca S.A. | $442.680 |
| 2157-531-SE13 | 17-04-2013 | Laboratorio Sanderson S.A. | $434.112 |
| 2157-530-SE13 | 17-04-2013 | Icu Medical Chile Limitada | $1.927.800 |
| 2157-492-SE13 | 12-04-2013 | Laboratorio Sanderson S.A. | $390.915 |
| 2157-422-SE13 | 01-04-2013 | Laboratorio Sanderson S.A. | $228.000 |
| 2157-392-SE13 | 19-03-2013 | Pfizer Chile S.A. | $2.760.800 |
| 2157-342-SE13 | 06-03-2013 | Icu Medical Chile Limitada | $1.618.400 |
| 2157-332-SE13 | 05-03-2013 | Laboratorio Sanderson S.A. | $157.080 |
| 2157-331-SE13 | 05-03-2013 | Farmaceutica Insuval S.A. | $113.050 |
| 2157-330-SE13 | 05-03-2013 | Productos Farmoquimicos Roche Limitada | $434.945 |
| 2157-286-SE13 | 26-02-2013 | Aventis Pharma Holding Gmbh | $1.749.300 |
| 2157-281-SE13 | 25-02-2013 | Pfizer Chile S.A. | $4.141.200 |
| 2157-282-SE13 | 25-02-2013 | Laboratorio Sanderson S.A. | $80.920 |
| 2157-255-SE13 | 19-02-2013 | Laboratorio Sanderson S.A. | $361.760 |
| 2157-160-SE13 | 28-01-2013 | Laboratorio Sanderson S.A. | $228.000 |
| 2157-122-SE13 | 16-01-2013 | Farmaceutica Insuval S.A. | $113.050 |
| 2157-116-SE13 | 16-01-2013 | Laboratorio Sanderson S.A. | $379.313 |
| 2157-120-SE13 | 16-01-2013 | Novofarma Service S.A. | $778.646 |
| 2157-121-SE13 | 16-01-2013 | Astrazeneca S.A. | $184.450 |
| 2157-131-SE13 | 16-01-2013 | Astrazeneca S.A. | $1.291.150 |
| 2157-104-SE13 | 14-01-2013 | Aventis Pharma Holding Gmbh | $1.982.540 |
| 2157-32-SE13 | 04-01-2013 | Laboratorio Sanderson S.A. | $180.880 |
| 2157-1841-SE12 | 18-12-2012 | Laboratorio Sanderson S.A. | $135.660 |
| 2157-1825-SE12 | 17-12-2012 | Icu Medical Chile Limitada | $1.618.400 |
| 2157-1826-SE12 | 17-12-2012 | Laboratorio Sanderson S.A. | $39.687 |
| 2157-1824-SE12 | 17-12-2012 | Pfizer Chile S.A. | $2.760.800 |
| 2157-1757-SE12 | 27-11-2012 | Laboratorio Sanderson S.A. | $271.320 |
| 2157-1722-SE12 | 19-11-2012 | Pfizer Chile S.A. | $2.760.800 |
| 2157-1700-SE12 | 14-11-2012 | Aventis Pharma Holding Gmbh | $1.399.440 |
| 2157-1693-SE12 | 14-11-2012 | Laboratorio Sanderson S.A. | $303.153 |
| 2157-1694-SE12 | 14-11-2012 | Productos Farmoquimicos Roche Limitada | $434.945 |
| 2157-1695-SE12 | 14-11-2012 | Astrazeneca S.A. | $184.450 |
| 2157-1696-SE12 | 14-11-2012 | Farmaceutica Insuval S.A. | $113.050 |
| 2157-1698-SE12 | 14-11-2012 | Pfizer Chile S.A. | $2.760.800 |
| 2157-1699-SE12 | 14-11-2012 | Icu Medical Chile Limitada | $928.200 |
| 2157-1586-SE12 | 24-10-2012 | Aventis Pharma Holding Gmbh | $1.399.440 |
| 2157-1535-SE12 | 18-10-2012 | Laboratorio Sanderson S.A. | $217.830 |
| 2157-1544-SE12 | 18-10-2012 | Productos Farmoquimicos Roche Limitada | $434.945 |
| 2157-1546-SE12 | 18-10-2012 | Pfizer Chile S.A. | $2.760.800 |
| 2157-1547-SE12 | 18-10-2012 | Icu Medical Chile Limitada | $928.200 |
| 2157-1545-SE12 | 18-10-2012 | Novofarma Service S.A. | $778.646 |
| 2157-1506-SE12 | 10-10-2012 | Astrazeneca S.A. | $1.106.700 |
| 2157-1422-SE12 | 26-09-2012 | Astrazeneca S.A. | $368.900 |
| 2157-1419-SE12 | 26-09-2012 | Laboratorio Sanderson S.A. | $456.000 |
| 2157-1420-SE12 | 26-09-2012 | Novofarma Service S.A. | $778.646 |
| 2157-1380-SE12 | 25-09-2012 | Farmaceutica Insuval S.A. | $226.100 |
| 2157-1381-SE12 | 25-09-2012 | Pfizer Chile S.A. | $2.760.800 |
| 2157-1382-SE12 | 25-09-2012 | Productos Farmoquimicos Roche Limitada | $521.934 |
| 2157-1368-SE12 | 24-09-2012 | Laboratorio Sanderson S.A. | $453.985 |
| 2157-1297-SE12 | 11-09-2012 | Laboratorio Sanderson S.A. | $228.000 |
| 2157-1289-SE12 | 06-09-2012 | Pfizer Chile S.A. | $2.760.800 |
| 2157-1207-SE12 | 13-08-2012 | Farmaceutica Insuval S.A. | $113.050 |
| 2157-1205-SE12 | 13-08-2012 | Icu Medical Chile Limitada | $1.618.400 |
| 2157-1208-SE12 | 13-08-2012 | Laboratorio Sanderson S.A. | $308.924 |
| 2157-1200-SE12 | 13-08-2012 | Pfizer Chile S.A. | $2.760.800 |
| 2157-1201-SE12 | 13-08-2012 | Aventis Pharma Holding Gmbh | $1.399.440 |
| 2157-1202-SE12 | 13-08-2012 | Astrazeneca S.A. | $368.900 |
| 2157-1204-SE12 | 13-08-2012 | Productos Farmoquimicos Roche Limitada | $434.945 |
| 2157-1183-SE12 | 10-08-2012 | Laboratorio Sanderson S.A. | $228.000 |
| 2157-1160-SE12 | 02-08-2012 | Astrazeneca S.A. | $368.900 |
| 2157-1158-SE12 | 01-08-2012 | Laboratorio Sanderson S.A. | $271.320 |
| 2157-1042-SE12 | 05-07-2012 | Laboratorio Sanderson S.A. | $224.196 |
| 2157-1043-SE12 | 05-07-2012 | Astrazeneca S.A. | $368.900 |
| 2157-1044-SE12 | 05-07-2012 | Farmaceutica Insuval S.A. | $113.050 |
| 2157-1045-SE12 | 05-07-2012 | Pfizer Chile S.A. | $2.760.800 |
| 2157-1046-SE12 | 05-07-2012 | Icu Medical Chile Limitada | $618.800 |
| 2157-1047-SE12 | 05-07-2012 | Aventis Pharma Holding Gmbh | $1.166.200 |
| 2157-714-SE12 | 09-05-2012 | Novofarma Service S.A. | $5.096.589 |
| 2157-715-SE12 | 09-05-2012 | Icu Medical Chile Limitada | $7.854.000 |
| 2157-716-SE12 | 09-05-2012 | Productos Farmoquimicos Roche Limitada | $5.219.340 |
| 2157-717-SE12 | 09-05-2012 | Laboratorio Sanderson S.A. | $2.281.230 |
| 2157-718-SE12 | 09-05-2012 | Astrazeneca S.A. | $7.082.880 |
| 2157-719-SE12 | 09-05-2012 | Aventis Pharma Holding Gmbh | $15.393.840 |
| 2157-720-SE12 | 09-05-2012 | Pfizer Chile S.A. | $33.129.600 |
| 2157-721-SE12 | 09-05-2012 | B Braun Medical SpA | $976.752 |
| 2157-722-SE12 | 09-05-2012 | Tecnofarma S.A. | $1.785.000 |
| 2157-723-SE12 | 09-05-2012 | Farmaceutica Insuval S.A. | $1.113.840 |
Fuente original:ficha mercadopublico.cl
